Cita APA

Zhao, Y., Zheng, R., Chen, J., & Ning, D. (2020). CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC). Cancer Cell Int.

Chicago Style Citation

Zhao, Yongsheng, Renyan Zheng, Jian Chen, i Dong Ning. "CircRNA CDR1as/miR-641/HOXA9 Pathway Regulated Stemness Contributes to Cisplatin Resistance in Non-small Cell Lung Cancer (NSCLC)." Cancer Cell Int 2020.

Cita MLA

Zhao, Yongsheng, Renyan Zheng, Jian Chen, i Dong Ning. "CircRNA CDR1as/miR-641/HOXA9 Pathway Regulated Stemness Contributes to Cisplatin Resistance in Non-small Cell Lung Cancer (NSCLC)." Cancer Cell Int 2020.